How should I clerk a patient with suspected breast cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

How to Clerk a Patient with Suspected Breast Cancer

Begin with a focused clinical assessment that includes specific breast cancer risk factors, detailed characterization of the breast abnormality, and immediate arrangement for triple diagnostic evaluation (clinical exam, imaging, and tissue diagnosis). 1

Essential History Components

Presenting Complaint Details

  • Duration of the lump or breast change and whether it has evolved in size or character 2
  • Previous breast biopsies or breast cancer history 2
  • Symptoms suggesting metastatic disease (bone pain, respiratory symptoms, neurological changes) - though these tests are only indicated if high tumor burden, aggressive biology, or symptomatic 1

Risk Factor Assessment

Document these systematically, though their presence or absence should not delay investigation of a palpable abnormality 2:

  • Family history: Specifically breast, ovarian, pancreatic, and prostate cancers in first- and second-degree relatives 1
  • Personal history: Age at menarche, parity, age at first birth, breastfeeding history
  • Menopausal status: If uncertain, measure serum estradiol and FSH levels 1
  • Previous radiation exposure to chest
  • BRCA mutation status if known

Reproductive and Hormonal History

  • Current menstrual status and regularity
  • Hormone replacement therapy or oral contraceptive use
  • Pregnancy and lactation history

Physical Examination Specifics

Breast Examination

Document features that distinguish malignant from benign lesions 2:

  • Lump characteristics: Size (measure in cm), location (clock position and distance from nipple), consistency (hard vs. soft), mobility, borders (well-defined vs. irregular)
  • Skin changes: Dimpling, peau d'orange, erythema, ulceration
  • Nipple changes: Retraction, discharge (note color and whether unilateral/bilateral), Paget's disease features
  • Bilateral examination is mandatory 1

Regional Lymph Node Assessment

  • Axillary nodes: All levels (I, II, III)
  • Supraclavicular nodes
  • Infraclavicular nodes
  • Document size, consistency, mobility, and number of palpable nodes 1

General Physical Examination

Only perform targeted examination for metastatic disease if clinically indicated (not routine) 1:

  • Chest auscultation if respiratory symptoms
  • Abdominal examination if hepatic symptoms
  • Skeletal examination if bone pain

Immediate Diagnostic Pathway

For Women ≥30 Years Old

Do not observe without further evaluation 3. Arrange immediately:

  1. Diagnostic mammography (bilateral) 1, 3
  2. Ultrasound of breast and regional lymph nodes - must be geographically correlated with the palpable abnormality 1, 3

For Women <30 Years Old

Ultrasound may suffice initially due to high sensitivity, particularly for low clinical suspicion masses or suspected simple cysts 3

Additional Imaging Considerations

MRI is not routine but should be arranged if 1:

  • Known BRCA mutation carrier
  • Lobular cancer suspected
  • Dense breasts on mammography
  • Suspected multifocality/multicentricity
  • Large discrepancy between imaging and clinical findings
  • Occult primary with positive axillary nodes

Tissue Diagnosis Requirements

Core needle biopsy is mandatory before any treatment - fine-needle aspiration alone is insufficient if systemic therapy is planned 1:

  • Obtain at least 2-3 cores under US or stereotactic guidance 1
  • If multifocal/multicentric disease suspected, biopsy all lesions 1
  • Place a marker clip or carbon in the tumor at biopsy 1
  • For suspicious lymph nodes: US-guided FNA or core biopsy with clip/carbon marking 1

Critical Pathology Requirements

The pathologist must report:

  • WHO histological classification and grade
  • ER, PgR, and HER2 status (mandatory for treatment planning) 1
  • Ki-67 proliferation index
  • TNM staging (8th edition AJCC) 1

Common Pitfalls to Avoid

  1. Never observe a palpable mass in women ≥30 without imaging - this is the most dangerous error 3
  2. Do not proceed with excisional biopsy first - core biopsy must precede surgery except in rare cases of repeatedly negative cores 1
  3. Ensure concordance between clinical findings, imaging, and pathology - if discordant, reassess completely 3, 4
  4. Do not skip lymph node assessment - both clinical and imaging evaluation are required 1
  5. Avoid routine metastatic workup in early-stage disease without symptoms or high-risk features 1

Documentation Essentials

Record in your clerking:

  • BI-RADS category from imaging (if available)
  • Whether triple assessment components are concordant
  • Menopausal status with objective measures if uncertain
  • Complete family pedigree for hereditary cancer syndromes
  • Timeline for diagnostic completion - this should be expeditious 2

The patient must be kept fully informed throughout the diagnostic process 2, and if reasonable doubt remains about benign vs. malignant nature after initial workup, biopsy is mandatory 2.

References

3
Guideline

breast cancer screening and diagnosis, version 3.2018, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2018

Related Questions

In breast cancer, does involvement of the nipple-areolar complex indicate the need for radiation therapy?
Is there evidence that aluminum-containing deodorants cause breast cancer or pose a health risk?
What cancer screening recommendations are appropriate for a 74‑year‑old female?
What is the standard multidisciplinary management for a newly diagnosed breast carcinoma, including surgical approach and options for immediate or delayed plastic reconstruction?
In a 34‑year‑old premenopausal woman with a 5 cm palpable breast mass suspicious for cancer, should the initial management be a core needle biopsy, lumpectomy, breast‑conserving surgery (BCS), or mastectomy?
If tetanus‑diphtheria‑pertussis (Tdap) vaccine is unavailable, should tetanus toxoid (TT) be administered as a 0.5 ml intramuscular injection?
What is the significance of a white blood cell count of 6.3 × 10⁹/L, absolute neutrophil count of 2.9 × 10⁹/L, and absolute lymphocyte count of 2.84 × 10⁹/L measured five months after an initial evaluation performed five years ago?
What does a lymphocyte count of 3,200 cells/µL five years ago, 2,800 cells/µL five months later, and 3,900 cells/µL today indicate?
What are the possible causes of seizures in a hypertensive emergency?
In a one‑month‑old infant with hiccups and abdominal discomfort, what assessment and management are indicated?
Should we decrease positive end-expiratory pressure (PEEP) before decreasing the fraction of inspired oxygen (FiO2)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.